The following statements regarding methylxanthines are true except:
**Core Concept**
Methylxanthines are a class of compounds that include caffeine, theophylline, and theobromine. They exert their effects by inhibiting phosphodiesterase (PDE) enzymes, which leads to an increase in intracellular cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) levels. This results in relaxation of smooth muscle, bronchodilation, and increased heart rate.
**Why the Correct Answer is Right**
Caffeine, a methylxanthine, acts as a non-selective adenosine receptor antagonist. Adenosine normally causes vasodilation and decreased heart rate. By blocking adenosine receptors, caffeine leads to increased sympathetic tone and release of catecholamines, causing increased heart rate and cardiac contractility. Additionally, methylxanthines inhibit PDE3, an enzyme involved in the regulation of cardiac contractility and relaxation.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is a true statement regarding methylxanthines. They are indeed used for their bronchodilatory effects in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
**Option B:** This option is a true statement regarding methylxanthines. They can also be used as a second-line treatment for heart failure, particularly in cases where beta-blockers are contraindicated.
**Option C:** This option is the false statement. Methylxanthines can actually increase intracranial pressure due to their vasodilatory effects and increased cerebral blood flow.
**Clinical Pearl / High-Yield Fact**
Methylxanthines can cause significant side effects, including insomnia, anxiety, and tachycardia, especially when used in high doses. It is essential to carefully monitor patients for these side effects, particularly those with pre-existing cardiac conditions.
**Correct Answer: C. Methylxanthines can actually increase intracranial pressure due to their vasodilatory effects and increased cerebral blood flow.**